However, concerns about Ozempic vision loss problems began to emerge in July 2024, following the publication of a study by Harvard researchers who found that patients using semaglutide may face a seven-fold increased risk for experiencing sudden vision changes, blurred sight, blindness or other symptoms linked to NAION, a rare condition where the optic nerve suffers from insufficient blood flow
S2CID 36383425
These have been shown to have antioxidant, anti-inflammatory, cholesterol-lowering, immunomodulatory, and cardioprotective effects (Adegbola et al., 2020
Can You Get Retatrutide Through a Clinical Trial
Yes, clinical data shows that subjects taking the formula exhibited a 12.45-fold increase in plasma GLP-1 levels relative to baseline at 90 minutes post-ingestion
Here is how the available evidence compares across medications